March 20 (Reuters) - FDA:
FDA: AWARE BARD PERIPHERAL VASCULAR ISSUED LETTER TO AFFECTED CUSTOMERS PROVIDING UPDATED INSTRUCTIONS FOR USE FOR ROTAREX ATHERECTOMY SYSTEMS
FDA: IDENTIFIED BARD PERIPHERAL VASCULAR'S ATHERECTOMY CATHETER SYSTEM RECALL AS THE MOST SERIOUS TYPE
FDA: BD REPORTED 30 SERIOUS INJURIES, 4 DEATHS ASSOCIATED WITH ATHERECTOMY CATHETER SYSTEM ISSUE FROM BARD PERIPHERAL VASCULAR
FDA: BD REPORTED 115 CASES REQUIRING ADDITIONAL INTERVENTION FOLLOWING HELIX FRACTURE AND/OR BREAKAGE RELATED TO ATHERECTOMY CATHETER SYSTEM ISSUE
(((( Reuters.Briefs@thomsonreuters.com ;));))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。